A novel modified paclitaxel-loaded discoidal recombinant high-density lipoproteins: Preparation, characterizations and in vivo evaluation

Asian Journal of Pharmaceutical Sciences

Volumn 8, Issue 1, 2013, Pages 9-17

  Zhang, Mengyuan ^a   Jia, Junting ^a   Liu, Jianping ^a   He, Hongliang ^a   Liu, Lisha ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug leakage; LCAT; Modified d rHDLs; Remodeling; Structural modification; Targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLESTEROL; DISCOIDAL RECOMBINANT HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOSOME; PACLITAXEL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SUCCINIC ANHYDRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MOLECULAR WEIGHT; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SURFACE TENSION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84881328859     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rensen PCN, de Vrueh RLA, Kuiper J, et al. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev. 2001, 47(2): 251-276.
2. Skajaa T, Cormode DP, Falk E, et al. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscl Throm Vas. 2010, 30(2): 169-176.
3. Mooberry LK, Nair M, Paranjape S, et al. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J Drug Target. 2010, 18(1): 53-58.
4. Cho KH. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 2009, 42(7):393-400.
5. Lacko AG, Nair M, Prokai L, et al. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. Expert Opin. Drug Delivery, 2007, 4(5): 665-675
6. Rader DJ. Molecular regulation of HDL metabolism and function: implicationsor novel therapies. J Clin Invest. 2006, 116(12): 3090.
7. McConathy WJ, Nair MP, Paranjape S, et al. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. Anti-cancer drugs.2008, 19(2): 183-188.
8. Lacko AG, Nair M, Paranjape S, et al. High density lipoprotein complexes asdelivery vehicles for anticancer drugs. Anticancer Res. 2002, 22(4): 2045-2050.
9. Corbin IR, Chen J, Cao W, et al. Enhanced cancer-targeted delivery usingengineered high-density lipoprotein-based nanocarriers. J Biomed Nanotechnology. 2007, 3(4): 367-376.
10. McConathy WJ, Paranjape S, Mooberry L, et al. Validation of the reconstitutedhigh-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein(DLF). Drug Delivery and Translational Research. 2011. 1(2): 113-120.
11. Wenli Z, Hongliang H, Jianping L, et al. Pharmacokinetics and atheroscleroticlesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials. 2012.
12. Junting J, Yan X, Jianping L, et al. Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins. J. Pharm Sci. 2012, 101(8): 2900-2908
13. Calabresi L, Franceschini G. Lecithin: cholesterol acyltransferase, high-densitylipoproteins, and atheroprotection in humans. Trends Cardiovas Med. 2010, 20(2):50-53.
14. Jonas A. Lecithin cholesterol acyltransferase. BBA-MOL Cell Biol L. 2000,1529(1): 245-256.
15. Calabresi L, Favari E, Moleri E, et al. Functional LCAT is not required formacrophage cholesterol efflux to human serum. Atherosclerosis. 2009, 204(1):141-146.
16. Shaikh VAE, Maldar NN, Lonikar SV, et al. Thermotropic liquid crystallinebehavior of cholesterol-linked hydroxyethyl cellulose. J. Appl Polym Sci. 1999,72(6): 763-770.
17. Haque A, Kito M. Lipophilization of soybean glycinin: covalent attachment to long chain fatty acids. Agric Biol Chem. 1982, 46.
18. Habeeb AFSA. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Analytical biochemistry. 1966, 14(3): 328-336.
19. Wenli Z, Yan X, Jianping L, et al. Structure and remodeling behavior ofdrug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model. IJP. 2011, 419(1): 314-321.
20. Jain SK, Chaurasiya A, Gupta Y, et al. Development and characterization of 5-FUbearing ferritin appended solid lipid nanoparticles for tumour targeting. J.microencapsulation. 2008, 25(5): 289-297.
21. Xu Y, Jin X, Ping Q, et al. A novel lipoprotein-mimic nanocarrier composed ofthe modified protein and lipid for tumor cell targeting delivery. J. ControlledRelease. 2010, 146(3): 299-308.
22. Oda MN, Hargreaves PL, Beckstead JA, et al. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. J Lipid Res. 2006, 47(2): 260-267.
23. Shi Y, Kim S, HuffTB, et al. Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nature Nanotech. 2009, 5(1): 80-87.
24. Guo LS, Hamilton RL, Goerke J, et al. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J Lipid Res. 1980, 21(8): 993-1003.